Fam Pract Manag. 2009 May-June;16(3):7.

I'd like to give my thanks to Drs. Paladine and Howard for stepping up to bat for our patients and our values in “Four Reasons Our Office Is Pharma-Free” (Opinion, March/April 2009). My office went pharma-free this year, and doing so has relieved the strain of pharma interruptions and their biases. One thing the article didn't mention is the potential for loss of revenue. Three or more drug rep visits could easily be replaced by one more patient visit per day, and that could bring in from $10,000 to $20,000 in revenue each year. At this time of declining reimbursement, how we spend our time matters more than ever.


Send your comments to fpmedit@aafp.org. Submission of a letter will be construed as granting AAFP permission to publish the letter in any of its publications in any form. We cannot respond to all letters we receive. Those chosen for publication will be edited for length and style.


Copyright © 2009 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact fpmserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


Mar-Apr 2018

Access the latest issue
of FPM journal

Read the Issue

FPM E-Newsletter

Sign up to receive FPM's free, weekly e-newsletter, "Quick Tips & Insights."

Sign Up Now


Helping Your Adolescent and Young Adult Patients Get the Preventive Care and Services They Need

The Adolescent Health Consortium Project has clarified clinical preventive service recommendations for adolescents and young adults.

Making Sense of MACRA: Navigate Changes to the Quality Payment Program in 2018

Here's how to succeed in the four performance categories of the Merit-based Incentive Payment System.